<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "1: revenue growth while controlling", fill: "#0093af"},
{source: "1: revenue growth while controlling", target: "1: market price", fill: "#0093af"},
{source: "1: market price", target: "1: common stock may decline", fill: "#0093af"},
{source: "1: revenue growth while controlling", target: "2: difficulties encountered by", fill: "#ff8c69"},
{source: "2: difficulties encountered by", target: "2: early stage", fill: "#ff8c69"},
{source: "2: early stage", target: "2: operations", fill: "#ff8c69"},
{source: "2: difficulties encountered by", target: "3: Consistent ", fill: "#e3256b"},
{source: "3: Consistent ", target: "3: early stage", fill: "#e3256b"},
{source: "3: early stage", target: "3: operations", fill: "#e3256b"},
{source: "3: operations", target: "3: incur significant", fill: "#e3256b"},
{source: "3: incur significant", target: "3: manufacturing processes", fill: "#e3256b"},
{source: "3: manufacturing processes", target: "3: consumer marketing campaign", fill: "#e3256b"},
{source: "3: consumer marketing campaign", target: "3: dental professional", fill: "#e3256b"},
{source: "3: dental professional", target: "3: marketing efforts", fill: "#e3256b"},
{source: "3: marketing efforts", target: "3: clinical research", fill: "#e3256b"},
{source: "3: clinical research", target: "3: education", fill: "#e3256b"},
{source: "3: education", target: "3: technological improvements", fill: "#e3256b"},
{source: "3: technological improvements", target: "3: development", fill: "#e3256b"},
{source: "3: development", target: "3: international sales", fill: "#e3256b"},
{source: "3: international sales", target: "3: intellectual property", fill: "#e3256b"},
{source: "3: intellectual property", target: "3: trade secrets", fill: "#e3256b"},
{source: "3: trade secrets", target: "3: quality assurance", fill: "#e3256b"},
{source: "3: quality assurance", target: "3: improvement initiatives", fill: "#e3256b"},
{source: "3: Consistent ", target: "4: Invisalign ", fill: "#c66"},
{source: "4: Invisalign ", target: "4: professionals", fill: "#c66"},
{source: "4: professionals", target: "4: second quarter", fill: "#c66"},
{source: "4: second quarter", target: "4: consumer marketing campaign involving", fill: "#c66"},
{source: "4: consumer marketing campaign involving", target: "4: television radio", fill: "#c66"},
{source: "4: Invisalign ", target: "7: profitability", fill: "#738678"},
{source: "7: profitability", target: "7: future periods", fill: "#738678"},
{source: "7: future periods", target: "7: revenues while controlling", fill: "#738678"},
{source: "7: profitability", target: "10: difficult", fill: "#008000"},
{source: "10: difficult", target: "10: historical growth rates", fill: "#008000"},
{source: "10: historical growth rates", target: "10: future periods", fill: "#008000"},
{source: "10: difficult", target: "11: profitability", fill: "#ff3800"},
{source: "11: profitability", target: "11: revenue growth", fill: "#ff3800"},
{source: "11: revenue growth", target: "11: otherwise meet", fill: "#ff3800"},
{source: "11: otherwise meet", target: "11: expectations", fill: "#ff3800"},
{source: "11: expectations", target: "11: securities analysts", fill: "#ff3800"},
{source: "11: securities analysts", target: "11: market price", fill: "#ff3800"},
{source: "11: market price", target: "11: common stock will", fill: "#ff3800"},
{source: "11: common stock will", target: "11: likely decline", fill: "#ff3800"},
{source: "11: profitability", target: "18: aggressive price competition from competitors", fill: "#fefe33"},
{source: "18: aggressive price competition from competitors", target: "18: OrthoClear ", fill: "#fefe33"},
{source: "18: OrthoClear ", target: "18: product orders", fill: "#fefe33"},
{source: "18: product orders", target: "18: unanticipated delays", fill: "#fefe33"},
{source: "18: unanticipated delays", target: "18: capacity", fill: "#fefe33"},
{source: "18: capacity", target: "18: disruptions", fill: "#fefe33"},
{source: "18: disruptions", target: "18: manufacturing process", fill: "#fefe33"},
{source: "18: manufacturing process", target: "18: unexpected turnover", fill: "#fefe33"},
{source: "18: unexpected turnover", target: "18: labor force", fill: "#fefe33"},
{source: "18: labor force", target: "18: introduction", fill: "#fefe33"},
{source: "18: introduction", target: "18: inaccurate forecasting", fill: "#fefe33"},
{source: "18: inaccurate forecasting", target: "18: revenues production", fill: "#fefe33"},
{source: "18: revenues production", target: "18: expenditures", fill: "#fefe33"},
{source: "18: expenditures", target: "18: connection with ongoing litigation", fill: "#fefe33"},
{source: "18: connection with ongoing litigation", target: "18: litigation", fill: "#fefe33"},
{source: "18: litigation", target: "18: OrthoClear ", fill: "#fefe33"},
{source: "18: OrthoClear ", target: "18: product mix due", fill: "#fefe33"},
{source: "18: product mix due", target: "18: alternative", fill: "#fefe33"},
{source: "18: alternative", target: "18: investments", fill: "#fefe33"},
{source: "18: investments", target: "18: enhancements", fill: "#fefe33"},
{source: "18: aggressive price competition from competitors", target: "27: This ", fill: "#682860"},
{source: "27: This ", target: "27: litigation", fill: "#682860"},
{source: "27: litigation", target: "27: could distract", fill: "#682860"},
{source: "27: could distract", target: "27: management", fill: "#682860"},
{source: "27: management", target: "27: operations", fill: "#682860"},
{source: "27: This ", target: "30: Chishti ", fill: "#a9a9a9"},
{source: "30: Chishti ", target: "30: several former", fill: "#a9a9a9"},
{source: "30: Chishti ", target: "31: OrthoClear ", fill: "#2a52be"},
{source: "31: OrthoClear ", target: "31: defendants", fill: "#2a52be"},
{source: "31: defendants", target: "31: unlawfully utilize", fill: "#2a52be"},
{source: "31: unlawfully utilize", target: "31: intellectual", fill: "#2a52be"},
{source: "31: intellectual", target: "31: property confidential", fill: "#2a52be"},
{source: "31: OrthoClear ", target: "32: complaint also", fill: "#e8000d"},
{source: "32: complaint also", target: "34: complaint seeks injunctive relief", fill: "#5218fa"},
{source: "34: complaint seeks injunctive relief", target: "34: monetary damages", fill: "#5218fa"},
{source: "34: complaint seeks injunctive relief", target: "41: On January ", fill: "#e4d00a"},
{source: "41: On January ", target: "41: complaint with", fill: "#e4d00a"},
{source: "41: complaint with", target: "41: International Trade Commission ITC ", fill: "#e4d00a"},
{source: "41: International Trade Commission ITC ", target: "41: importation into", fill: "#e4d00a"},
{source: "41: importation into", target: "41: United States ", fill: "#e4d00a"},
{source: "41: United States ", target: "41: manufactured", fill: "#e4d00a"},
{source: "41: manufactured", target: "41: OrthoClear in Pakistan ", fill: "#e4d00a"},
{source: "41: OrthoClear in Pakistan ", target: "41: intellectual", fill: "#e4d00a"},
{source: "41: intellectual", target: "41: property rights", fill: "#e4d00a"},
{source: "41: On January ", target: "42: The ITC Complaint ", fill: "#faf0e6"},
{source: "42: The ITC Complaint ", target: "42: investigation", fill: "#faf0e6"},
{source: "42: investigation", target: "42: ultimately issue", fill: "#faf0e6"},
{source: "42: ultimately issue", target: "42: exclusionary", fill: "#faf0e6"},
{source: "42: exclusionary", target: "42: enforced by", fill: "#faf0e6"},
{source: "42: enforced by", target: "42: OrthoClear ", fill: "#faf0e6"},
{source: "42: OrthoClear ", target: "42: aligners from", fill: "#faf0e6"},
{source: "42: aligners from", target: "42: importation into", fill: "#faf0e6"},
{source: "42: importation into", target: "42: United States", fill: "#faf0e6"},
{source: "42: The ITC Complaint ", target: "47: litigation", fill: "#dda0dd"},
{source: "47: litigation", target: "47: adversely", fill: "#dda0dd"},
{source: "47: adversely", target: "47: operations", fill: "#dda0dd"},
{source: "47: litigation", target: "48: legal proceedings", fill: "#9b870c"},
{source: "48: legal proceedings", target: "START_HERE", fill: "#9b870c"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Oil and Gas Refining and Marketing and Transportation</td>
    </tr>
    <tr>
      <td>Asset Management and Custody Banks</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Intelligence</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Judicial</td>
    </tr>
    <tr>
      <td>Leadership</td>
    </tr>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Provide</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Agree</td>
    </tr>
    <tr>
      <td>Demand</td>
    </tr>
    <tr>
      <td>Human death</td>
    </tr>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Vote</td>
    </tr>
    <tr>
      <td>Sports contest</td>
    </tr>
    <tr>
      <td>Reward</td>
    </tr>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Promise</td>
    </tr>
    <tr>
      <td>Psychological state</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Contract_research_organization">Contract research organization</a></td>
      <td>In the life sciences, a contract research organization (CRO) is a company that provides support to the  pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis.  A CRO may provide such services as biopharmaceutical development, biologic assay development, commercialization, clinical development, clinical trials management, pharmacovigilance, outcomes research, and Real world evidence.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Pricing">Pricing</a></td>
      <td>Pricing is the process whereby a business sets the price at which it will sell its products and services, and may be part of the business's marketing plan. In setting prices, the business will take into account the price at which it could acquire the goods, the manufacturing cost, the marketplace, competition, market condition, brand, and quality of product.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Market_structure">Market structure</a></td>
      <td>Market structure, in economics, depicts how firms are differentiated and categorised based on the types of goods they sell (homogeneous/heterogeneous) and how their operations are affected by external factors and elements. Market structure makes it easier to understand the characteristics of diverse markets.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_research">Operations research</a></td>
      <td>Operations research (British English: operational research), often shortened to the initialism OR, is a discipline that deals with the development and application of advanced analytical methods to improve decision-making. It is sometimes considered to be a subfield of mathematical sciences.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Professional_development">Professional development</a></td>
      <td>Professional development is learning to earn or maintain professional credentials such as academic degrees to formal coursework, attending conferences, and informal learning opportunities situated in practice. It has been described as intensive and collaborative, ideally incorporating an evaluative stage.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Intellectual_property_infringement">Intellectual property infringement</a></td>
      <td>An intellectual property (IP) infringement is the infringement or violation of an intellectual property right. There are several types of intellectual property rights, such as copyrights, patents, trademarks, industrial designs, and trade secrets.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Soft_intellectual_property">Soft intellectual property</a></td>
      <td>Soft intellectual property (also sometimes, and confusingly (see below), abbreviated to "soft IP") is sometimes used to refer to trademarks, copyright, design rights and passing off, in contrast to "hard intellectual property", which is sometimes used to refer to patents.  Use of this phrase is controversial among IP practitioners.The phrase "soft intellectual property" or Soft IP also refers to a system for licensing patents proposed in 2008.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Defend_Trade_Secrets_Act">Defend Trade Secrets Act</a></td>
      <td>The Defend Trade Secrets Act of 2016 (DTSA) (Pub.L. 114–153 (text) (PDF), 130 Stat. 376, enacted May 11, 2016, codified at 18 U.S.C. § 1836, et seq.) is a United States federal law that allows an owner of a trade secret to sue in federal court when its trade secrets have been misappropriated.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Zia_Chishti">Zia Chishti</a></td>
      <td>Muhammad Ziaullah Khan Chishti (born 1971) is a Pakistani–American investor and business executive. He is the founder of Afiniti and TRG Global.After starting his career as a Morgan Stanley investment banker, Chishti invented the medical device Invisalign and co-founded Align Technology to market the product in 1997.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Orthodontics">Orthodontics</a></td>
      <td>Orthodontics is a dentistry specialty that addresses the diagnosis, prevention, and correction of mal-positioned teeth and jaws, and misaligned bite patterns. It may also address the modification of facial growth, known as dentofacial orthopedics.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_2009_albums">List of 2009 albums</a></td>
      <td>The following is a list of music albums, EPs, and mixtapes released in 2012. These are notable albums, defined as having received significant coverage from reliable sources independent of the subject.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Profit_(economics)">Profit (economics)</a></td>
      <td>An economic profit is the difference between the revenue a  commercial entity has received from its outputs and the opportunity costs of its inputs. It equals to total revenue minus total cost, including both explicit and implicit costs.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Profitability_index">Profitability index</a></td>
      <td>Profitability index (PI), also known as profit investment ratio (PIR) and value investment ratio (VIR), is the ratio of payoff to investment of a proposed project. It is a useful tool for ranking projects because it allows you to quantify the amount of value created per unit of investment.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Small_Is_Profitable">Small Is Profitable</a></td>
      <td>Small Is Profitable: The Hidden Economic Benefits of Making Electrical Resources the Right Size is a 2002 book by energy analyst Amory Lovins and others.  The book describes 207 ways in which the size of "electrical resources"—devices that make, save, or store electricity—affects their economic value.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Strategic_planning">Strategic planning</a></td>
      <td>Strategic planning is an organization's process of defining its strategy or direction, and making decisions on allocating its resources to attain strategic goals.\nIt may also extend to control mechanisms for guiding the implementation of the strategy.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Permanent_income_hypothesis">Permanent income hypothesis</a></td>
      <td>The permanent income hypothesis (PIH) is a model in the field of economics to explain the formation of consumption patterns. It suggests consumption patterns are formed from future expectations and consumption smoothing.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Depreciation">Depreciation</a></td>
      <td>In several fields, especially computing, deprecation is the discouragement of use of some terminology, feature, design, or practice, typically because it has been superseded or is no longer considered efficient or safe, without completely removing it or prohibiting its use. Typically, deprecated materials are not completely removed to ensure legacy compatibility or back up practice in case new methods are not functional in an odd scenario.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/The_Difficult_Couple">The Difficult Couple</a></td>
      <td>The Difficult Couple (Chinese: 难夫难妻; pinyin: Nànfū Nànqī), also translated as Die for Marriage, is a 1913 Chinese film. It is known for being the earliest Chinese feature film.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Rational_expectations">Rational expectations</a></td>
      <td>In economics, "rational expectations" are model-consistent expectations, in that agents inside the model are assumed to "know the model" and on average take the model's predictions as valid. Rational expectations ensure internal consistency in models involving uncertainty.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Strategic_litigation">Strategic litigation</a></td>
      <td>Strategic litigation, also known as impact litigation, is the practice of bringing lawsuits intended to effect societal change. Impact litigation cases may be class action lawsuits or individual claims with broader significance, and may rely on statutory law arguments or on constitutional claims.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Vexatious_litigation">Vexatious litigation</a></td>
      <td>Vexatious litigation is legal action which is brought  solely to harass or subdue an adversary. It may take the form of a primary frivolous lawsuit or may be the repetitive, burdensome, and unwarranted filing of meritless motions in a matter which is otherwise a meritorious cause of action.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Management">Management</a></td>
      <td>Management (or managing) is the administration of an organization, whether it is a business, a non-profit organization, or a government body. It is the art and science of managing resources of the business.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Maudood_Chishti">Maudood Chishti</a></td>
      <td>Maudood Chishti (Urdu: مودود چشتی) (also known as Qutubuddin, Shams Sufiyaan and Chiraag Chishtiyaan) was an early day Sufi Saint, a successor to his father and master Abu Yusuf Bin Saamaan, twelfth link in the Sufi silsilah of Chishti Order, and the Master of Shareef Zandani. He was born around 430 Hijri in the city of Chisht.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Intellectual">Intellectual</a></td>
      <td>An intellectual is a person who engages in critical thinking, research, and reflection about the reality of society, and who proposes solutions for the normative problems of society. Coming from the world of culture, either as a creator or as a mediator, the intellectual participates in politics, either to defend a concrete proposition or to denounce an injustice, usually by either rejecting or producing or extending an ideology, and by defending a system of values.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Landlord–tenant_law">Landlord–tenant law</a></td>
      <td>Landlord–tenant law is a part of the common law that details the rights and duties of landlords and tenants.  It includes elements of both real property law (specifically conveyances) and contract law.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Importation_Act_1455">Importation Act 1455</a></td>
      <td>The Importation Act 1455 (33 Henry VI c. 5) was an act of the Parliament of England passed during the reign of Henry VI.\nIn 1455, London silkwomen complained that the Lombards were importing "ribbands and chains, falsely and deceitfully wrought, all manner girdles and other things concerning the said mistery and occupation, in no manner wise bringing in any good silk unwrought as they were wont to bring heretofore".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Agreement_on_the_Importation_of_Educational,_Scientific_and_Cultural_Materials">Agreement on the Importation of Educational, Scientific and Cultural Materials</a></td>
      <td>The Agreement on the Importation of Educational, Scientific and Cultural Materials (also known as the Florence Agreement) is a 1950 UNESCO treaty whereby states agree to not impose customs duties on certain educational, scientific, and cultural materials that are imported.\n\n\n== Content ==\nThe materials covered by the treaty include printed books, newspapers, periodicals, government publications, printed music, works of art, antiques over 100 years old, scientific instruments used in education or research, and educational films.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_states_and_territories_of_the_United_States">List of states and territories of the United States</a></td>
      <td>The United States of America is a federal republic consisting of 50 states, a federal district (Washington, D.C., the capital city of the United States), five major territories, and various minor islands. The 48 contiguous states and Washington, D.C., are in North America between Canada and Mexico.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Criminal_investigation">Criminal investigation</a></td>
      <td>Criminal investigation is an applied science that involves the study of facts that are then used to inform criminal trials. A complete criminal investigation can include searching, interviews, interrogations, evidence collection and preservation, and various methods of investigation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Hostile_witness">Hostile witness</a></td>
      <td>A hostile witness, also known as an adverse witness or an unfavorable witness, is a witness at trial whose  testimony on direct examination is either openly antagonistic or appears to be contrary to the legal position of the party who called the witness. This concept is used in the legal proceedings in the United States, and analogues of it exist in other legal systems in Western countries.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Yangju_highway_incident">Yangju highway incident</a></td>
      <td>The Yangju highway incident, also known as the Yangju training accident or Highway 56 Accident, was a double-homicide that occurred on June 13, 2002, in Yangju, Gyeonggi-do, South Korea. A United States Army armored vehicle-launched bridge, returning to base in Uijeongbu on a public road after training maneuvers in the countryside, struck and killed two 14-year-old South Korean schoolgirls, Shin Hyo-sun (Korean: 신효순) and Shim Mi-seon (Korean: 심미선).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Francesco_Schettino">Francesco Schettino</a></td>
      <td>Francesco Schettino (Italian pronunciation: [franˈtʃesko sketˈtiːno]; born 14 November 1960) is an Italian ex-sea captain who commanded the cruise ship Costa Concordia when it struck an underwater rock and capsized with the deaths of 32 passengers and crew off the Italian island of Giglio on 13 January 2012. In 2015, he was sentenced to sixteen years in prison for his role in the incident.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Murder_of_Mollie_Tibbetts">Murder of Mollie Tibbetts</a></td>
      <td>On July 18, 2018, University of Iowa student Mollie Cecilia Tibbetts disappeared while jogging near her home in Brooklyn, Iowa. A month later, police identified 24-year-old Cristhian Bahena Rivera as a suspect in connection with the disappearance; surveillance footage showed Rivera's car following Tibbetts on her jog.</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>ALIGN TECHNOLOGY INC      ITEM 1A   RISK FACTORS       If we fail to sustain our <font color="blue"><font color="blue">revenue growth</font> while controlling</font> our expenses, the     <font color="blue">market price</font> of our <font color="blue">common stock may decline</font></td>
    </tr>
    <tr>
      <td>You  should consider our business and prospects in light of the risks,     expenses and <font color="blue"><font color="blue">difficult</font>ies encountered by</font> a company in an <font color="blue">early stage</font> of     <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td><font color="blue">Consistent </font>with a company in an <font color="blue">early stage</font> of <font color="blue">operations</font>, we     continue to <font color="blue">incur significant</font> operating expenses to:       ·        develop  new  software  and  increase  the  automation of our     <font color="blue"><font color="blue">manufacturing process</font>es</font>;       ·       execute our <font color="blue">consumer marketing campaign</font> and <font color="blue">dental professional</font>     <font color="blue">marketing efforts</font>;       ·       execute <font color="blue">clinical research</font> and <font color="blue">education</font> plans;       ·       develop <font color="blue">technological improvements</font> to our products and new product     <font color="blue">development</font>;       ·       continue our <font color="blue">international sales</font> and <font color="blue">marketing efforts</font>;       ·       protect our <font color="blue"><font color="blue">intellectual</font> property</font>, including <font color="blue">trade secrets</font>; and       ·       undertake <font color="blue">quality assurance</font> and <font color="blue">improvement initiatives</font></td>
    </tr>
    <tr>
      <td>For instance, in an effort to raise the profile of <font color="blue">Invisalign </font>and drive     prospective patients to our most experienced <font color="blue">dental professional</font>s, in the     <font color="blue">second quarter</font> of 2005, we launched a <font color="blue">consumer marketing campaign</font> involving     television, radio and print media</td>
    </tr>
    <tr>
      <td><font color="blue">Marketing </font>programs of this nature are     expensive  and may have limited success, if any, and may not result in     <font color="blue">revenue generation commensurate with</font> its costs</td>
    </tr>
    <tr>
      <td>While we achieved <font color="blue"><font color="blue">profitability</font> beginning</font> in the <font color="blue">fourth quarter</font> of fiscal     2003, we experienced a net loss in the <font color="blue">third quarter</font> of 2005</td>
    </tr>
    <tr>
      <td>If we are to     achieve  <font color="blue">profitability</font>  in <font color="blue">future periods</font>, we will need to continue to     increase our revenues, while controlling our expenses</td>
    </tr>
    <tr>
      <td>We generated positive     operating <font color="blue">cash flow</font> for the first time in fiscal year 2003 and continued to     generate  positive  operating <font color="blue">cash flow</font> in fiscal years 2004 and 2005</td>
    </tr>
    <tr>
      <td>However, we cannot be certain that we will be able to sustain or increase     such positive <font color="blue">cash flow</font> from <font color="blue">operations</font>, from period to period, in the     future</td>
    </tr>
    <tr>
      <td>Because our business is evolving, it is <font color="blue">difficult</font> to predict our     future operating results or levels of growth, and we may not be able to     sustain our <font color="blue">historical growth rates</font> in <font color="blue">future periods</font></td>
    </tr>
    <tr>
      <td>If we do not increase     <font color="blue">profitability</font>  or <font color="blue">revenue growth</font> or <font color="blue">otherwise meet</font> the <font color="blue">expectations</font> of     <font color="blue">securities analysts</font> or investors, the <font color="blue">market price</font> of our <font color="blue">common stock will</font>     <font color="blue">likely decline</font></td>
    </tr>
    <tr>
      <td>We have a limited operating history and expect our <font color="blue">future financial</font> results     to <font color="blue">fluctuate which may</font> cause <font color="blue">volatility</font> in our stock price</td>
    </tr>
    <tr>
      <td>We  were  incorporated  in April 1997 and <font color="blue">began sales</font> of <font color="blue">Invisalign </font>in     July 1999</td>
    </tr>
    <tr>
      <td>Thus,  we have a limited operating history, which makes it     <font color="blue">difficult</font> to evaluate our <font color="blue">future prospects</font></td>
    </tr>
    <tr>
      <td>In addition, we expect our     <font color="blue">future quarterly</font> and annual operating results to <font color="blue">fluctuate as</font> we focus on     increasing our <font color="blue">commercial sales</font></td>
    </tr>
    <tr>
      <td>These <font color="blue">fluctuations could</font> cause our stock     price to decline</td>
    </tr>
    <tr>
      <td>Some of the factors that could cause our operating results     to fluctuate include:       ·       the <font color="blue">development</font> and marketing of <font color="blue">directly competitive products by</font>     existing and new competitors, such as OrthoClear, Inc</td>
    </tr>
    <tr>
      <td>;       ·       <font color="blue">aggressive price competition from competitors</font>, including OrthoClear;       ·       changes in the timing of <font color="blue">product orders</font>;       19     ______________________________________________________________________       ·       <font color="blue">unanticipated delays</font> in production caused by insufficient <font color="blue">capacity</font>,     any <font color="blue">disruptions</font> in the <font color="blue">manufacturing process</font>, including as a result of     <font color="blue">unexpected turnover</font> in the <font color="blue">labor force</font> or the <font color="blue">introduction</font> of new production     processes;       ·       <font color="blue">inaccurate forecasting</font> of revenues, production and other operating     costs;       ·       costs and <font color="blue">expenditures</font> in <font color="blue">connection with ongoing <font color="blue">litigation</font></font>, in     particular the <font color="blue">litigation</font> related to OrthoClear;       ·        changes  in <font color="blue">product mix due</font> to the <font color="blue">introduction</font> of <font color="blue">Invisalign </font>    Express, a lower-cost <font color="blue">alternative</font> for treating less complex cases; and       ·       <font color="blue">investments</font> in research and <font color="blue">development</font> to develop new products and     <font color="blue">enhancements</font> to Invisalign</td>
    </tr>
    <tr>
      <td>To  respond  to  these and other factors, we may need to make business     <font color="blue">decisions</font>  that  could  <font color="blue"><font color="blue">adversely</font> affect</font> our operating results such as     <font color="blue">modifications</font> to our <font color="blue">pricing policy</font>, business structure or <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td><font color="blue">Most     </font>of  our  expenses,  such  as  employee  <font color="blue">compensation</font> and lease payment     <font color="blue">obligations</font>, are <font color="blue">relatively</font> fixed in the short term</td>
    </tr>
    <tr>
      <td>Moreover, our expense     levels are based, in part, on our <font color="blue">expectations</font> regarding <font color="blue">future revenue</font>     levels</td>
    </tr>
    <tr>
      <td>As a result, if our revenues for a <font color="blue">particular period fall</font> below our     <font color="blue">expectations</font>, we may be unable to <font color="blue">adjust spending quickly enough</font> to offset     any shortfall in revenues</td>
    </tr>
    <tr>
      <td>Therefore, our operating results for a given     <font color="blue">period may</font> be <font color="blue"><font color="blue">adversely</font> affect</font>ed</td>
    </tr>
    <tr>
      <td>Due to these and other factors, we believe     that quarter-to-quarter comparisons of our operating results may not be     <font color="blue">meaningful</font></td>
    </tr>
    <tr>
      <td>You should not rely on our results for any <font color="blue">one quarter as</font> an     <font color="blue">indication</font> of our <font color="blue">future performance</font></td>
    </tr>
    <tr>
      <td>We  are <font color="blue">currently involved</font> in <font color="blue">litigation</font> with <font color="blue">several former</font> employees     stemming  from  our efforts to protect our <font color="blue"><font color="blue">intellectual</font> property</font></td>
    </tr>
    <tr>
      <td><font color="blue">This     </font><font color="blue">litigation</font> is costly and <font color="blue">could distract</font> our <font color="blue">management</font> and cause a decline     in our results of <font color="blue">operations</font> and stock price</td>
    </tr>
    <tr>
      <td>We  seek  to  <font color="blue">diligently</font>  protect our <font color="blue"><font color="blue">intellectual</font> property</font> rights</td>
    </tr>
    <tr>
      <td>On     February 2, 2005 we filed a <font color="blue">complaint against</font> OrthoClear, Inc, <font color="blue">OrthoClear </font>    Holdings, Inc,  Mr</td>
    </tr>
    <tr>
      <td>Chishti,  one of our founders, and <font color="blue">several former</font>     employees</td>
    </tr>
    <tr>
      <td>Among  other things, the complaint alleges tort, contract,     statutory and <font color="blue">common law</font> causes of action arising from <font color="blue">OrthoClear </font>and the     individual <font color="blue">defendants</font>’ alleged plan to <font color="blue">unlawfully utilize</font> our <font color="blue">intellectual</font>     property, confidential information and employees</td>
    </tr>
    <tr>
      <td>The <font color="blue">complaint also</font> alleges     that  OrthoClear,  Mr</td>
    </tr>
    <tr>
      <td>Chishti,  and other <font color="blue">defendants</font> are in breach of     contractual <font color="blue">obligations</font>, statutory law and <font color="blue">common law</font> for attempting to     <font color="blue">intentionally interfere</font> and disrupt our ongoing business <font color="blue">operations</font> and     <font color="blue">improperly gain access</font> to our <font color="blue">customer relationships</font> and <font color="blue">trade secrets</font></td>
    </tr>
    <tr>
      <td>The     <font color="blue">complaint seeks <font color="blue">injunctive relief</font></font> and <font color="blue">monetary damages</font> in an amount to be     determined</td>
    </tr>
    <tr>
      <td>The complaint alleges <font color="blue">numerous violations</font> of the federal Lanham     Act (15 USC §1051 et seq</td>
    </tr>
    <tr>
      <td>) by <font color="blue">OrthoClear </font>and its officers and employees</td>
    </tr>
    <tr>
      <td>These violations include unfair competition, trademark infringement and     <font color="blue">false advertising</font></td>
    </tr>
    <tr>
      <td>The <font color="blue">complaint also</font> alleges <font color="blue">violations by</font> <font color="blue">OrthoClear </font>of     California’s Unfair Practices Act (California Business and Professions Code     §17200  et  seq</td>
    </tr>
    <tr>
      <td><font color="blue">On January </font>11, 2006, we filed a <font color="blue">complaint with</font> the     International Trade Commission (“ITC”) against OrthoClear, seeking to halt     the <font color="blue">importation into</font> the <font color="blue"><font color="blue">United States</font> </font>of infringing aligners <font color="blue">manufactured</font>     by <font color="blue">OrthoClear </font>in Pakistan in violation of our patents and other <font color="blue">intellectual</font>     <font color="blue">property rights</font></td>
    </tr>
    <tr>
      <td><font color="blue">The ITC Complaint </font>requests the ITC institute an immediate     <font color="blue">investigation</font> and <font color="blue">ultimately issue</font> an <font color="blue">exclusionary</font> order, <font color="blue">enforced by</font> US     Customs  and  Border  Protection,  excluding  <font color="blue">OrthoClear </font><font color="blue">aligners from</font>     <font color="blue">importation into</font> the <font color="blue">United States</font></td>
    </tr>
    <tr>
      <td><font color="blue">The ITC Complaint </font><font color="blue">also requests</font> the ITC     <font color="blue">issue two cease</font> and <font color="blue">desist orders specifically preventing</font> <font color="blue">OrthoClear </font>from     <font color="blue">importing infringing aligners</font> and <font color="blue">from selling</font> in the <font color="blue"><font color="blue">United States</font> </font>imported     <font color="blue">OrthoClear </font> aligners</td>
    </tr>
    <tr>
      <td>The  ITC  has  determined to institute a formal     <font color="blue">investigation</font></td>
    </tr>
    <tr>
      <td>In addition, on January 11, 2006, we filed a <font color="blue">federal court</font>     <font color="blue">patent infringement action</font> in the Western District of Wisconsin (Madison)</td>
    </tr>
    <tr>
      <td>This federal action seeks <font color="blue">monetary damages</font> and an injunction to augment the     <font color="blue">exclusionary</font> relief available from the <font color="blue">ITC       </font>20     ______________________________________________________________________       Although each of these lawsuits is in the <font color="blue">early stage</font>s, litigating claims of     this type, whether or not ultimately determined in our favor or <font color="blue">settled by</font>     us, is costly and diverts the efforts and attention of our <font color="blue">management</font> and     <font color="blue">technical personnel from normal</font> business <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Any of these results     from our <font color="blue">litigation</font> could <font color="blue"><font color="blue">adversely</font> affect</font> our results of <font color="blue">operations</font> and     stock price</td>
    </tr>
    <tr>
      <td>In addition, we are currently a party to various other <font color="blue">legal proceedings</font> and     claims</td>
    </tr>
    <tr>
      <td><font color="blue">Management </font>does not believe that the <font color="blue">ultimate outcome</font> of these other     <font color="blue">legal proceedings</font> and claims will have a material adverse effect on our     financial  position  or  results  of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>However, in the Ormco     <font color="blue">litigation</font>, there is no assurance that the court’s decision will not be     overturned  on  appeal</td>
    </tr>
    <tr>
      <td>In addition, <font color="blue">litigation</font> is subject to inherent     <font color="blue">uncertainties</font> and <font color="blue"><font color="blue">unfavorable ruling</font>s could</font> occur</td>
    </tr>
    <tr>
      <td>An <font color="blue">unfavorable ruling</font>     could include <font color="blue">monetary damages</font> or, in cases where <font color="blue">injunctive relief</font> is     sought, an injunction prohibiting us <font color="blue">from selling</font> our products</td>
    </tr>
    <tr>
      <td>Any of these     results from our <font color="blue">litigation</font> could <font color="blue"><font color="blue">adversely</font> affect</font> our results of <font color="blue">operations</font>     and stock price</td>
    </tr>
  </tbody>
</table>